Eli & Co Lilly, 10% Owner at Zymeworks Inc. (ZYME), sold 10,960 shares at $14.33 ($157K) on 2018-08-13, disclosed to the SEC on 2018-08-14.
Open-market sale of $157k ZYME by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.28 | 1,898 | $27K | 17.3% |
| 2 | $14.33 | 4,531 | $65K | 41.4% |
| 3 | $14.33 | 4,531 | $65K | 41.4% |
| Total | $14.32 avg | 10,960 | $157K | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |